is semaglutide and wegovy the same US FDA approves weight loss drug to prevent cardiovascular events Same ingredient, different purpose 🌿

Losing just 1 to 2 percent of your body weight through sweat can lead to an increased heart rate, higher core temperature, as well as decreased cardiac output, time to exhaustion, and power

This is particularly relevant since GLP-1 therapies have been shown to reduce hospitalizations related to heart failure

Combined with a high-protein diet, training, and quality sleep, these peptides can significantly enhance recovery, fat loss, and muscle growth in a way that mimics your bodys natural rhythms

D.KofmanE.GlassC

They can grow to 1521 cm long and 57.5 cm wide [1,10]

[5] [2] Patients starting GLP-1 therapy should be aware of: Potential mood changes during the adjustment period, particularly if experiencing significant gastrointestinal side effects The importance of continuing existing mental health treatments unless advised otherwise by their healthcare team Realistic expectations regarding weight loss and metabolic improvements, as unrealistic goals can lead to disappointment Healthcare professionals prescribing GLP-1 agonists should: Screen for depression and anxiety at baseline and during follow-up appointments Monitor for mood changes , particularly in patients with pre-existing mental health conditions Ensure coordinated care between diabetes/obesity services and mental health teams when appropriate It is essential to recognise that GLP-1 agonists are not a substitute for evidence-based depression treatments, including psychological therapies and antidepressant medications when indicated